galactose has been researched along with Liver Failure, Acute in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Jiang, X; Liu, S; Wei, F; Yin, R; Zhang, X | 1 |
| Chen, L; Jiang, Y; Jin, H; Lin, Y; Lv, W; Zheng, Y | 1 |
| Blaga, L; Căinap, SS; Deleanu, C; Fufezan, O; Grama, A; Militaru, M; Nicolescu, A; Pop, I; Pop, TL; Sîrbe, C; Tita, G; Vințan, MA; Vulturar, R | 1 |
| Li, R; Liang, S; Liu, S; Liu, Y; Ma, Y; Wang, X; Yao, S; Zeng, H; Zhang, J; Zhou, X; Zhu, L | 1 |
| Bikhchandani, J; Dennison, A; Illouz, S; Metcalfe, M; Puls, F | 1 |
| Chen, D; Chen, G; Ichim, TE; Jiang, N; McAlister, V; Min, WP; Quan, D; Siu, K; Wang, H; Zhang, X; Zheng, X | 1 |
| Filippi, C; Hayes, PC; Keatch, SA; Nelson, LJ; Plevris, JN; Rangar, D | 1 |
| Arkosy, M; Fazakas, J; Füle, B; Hidvégi, M; Mándli, T; Németh, E; Ther, G; Tóth, S | 1 |
| Batømunkh, M; Hagihara, M; Shimura, T; Takebe, K; Tsuji, K | 1 |
| Su, S; Tan, R; Zhou, C; Zhou, Z | 1 |
| Dong, F; Feng, B; Gao, Y; Liu, F; Wei, L; Wu, S | 1 |
1 review(s) available for galactose and Liver Failure, Acute
| Article | Year |
|---|---|
[Evaluation of liver function before living donor liver transplantation and liver resection].
Topics: Aminopyrine; Biliary Tract; Breath Tests; Carcinoma, Hepatocellular; Cholangiocarcinoma; Galactose; Hepatectomy; Humans; Indocyanine Green; Liver; Liver Circulation; Liver Failure, Acute; Liver Function Tests; Liver Neoplasms; Liver Transplantation; Living Donors; Oxidative Stress; Portal System; Predictive Value of Tests; Radionuclide Imaging; Serum Albumin; Tomography, X-Ray Computed | 2008 |
10 other study(ies) available for galactose and Liver Failure, Acute
| Article | Year |
|---|---|
The Qingchangligan Formula Alleviates Acute Liver Failure by Regulating Galactose Metabolism and Gut Microbiota.
Topics: Animals; Carbohydrate Metabolism; Disease Models, Animal; Drugs, Chinese Herbal; Galactose; Gastrointestinal Microbiome; Humans; Liver; Liver Failure, Acute; Rats; RNA, Ribosomal, 16S | 2021 |
Gensenoside Rg1 protects against lipopolysaccharide- and d-galactose-induced acute liver failure via suppressing HMGB1-mediated TLR4-NF-κB pathway.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Cell Line; Epithelial Cells; Galactose; Gene Expression Regulation; Ginsenosides; Glutathione; HMGB1 Protein; Humans; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Signal Transduction; Superoxide Dismutase; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2021 |
Novel Mutation in GALT Gene in Galactosemia Patient with Group B Streptococcus Meningitis and Acute Liver Failure.
Topics: Child, Preschool; Developed Countries; Female; Follow-Up Studies; Galactitol; Galactose; Galactosemias; Humans; Infant, Newborn; Lactose Tolerance Test; Liver Failure, Acute; Magnetic Resonance Spectroscopy; Meningitis, Bacterial; Mutation; Neonatal Screening; Romania; Streptococcal Infections; Streptococcus; UTP-Hexose-1-Phosphate Uridylyltransferase | 2019 |
Galactose protects hepatocytes against TNF-α-induced apoptosis by promoting activation of the NF-κB signaling pathway in acute liver failure.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cytokines; Galactose; Hepatocytes; Humans; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Protective Agents; Signal Transduction; Tumor Necrosis Factor-alpha | 2015 |
Extracorporeal liver perfusion system for artificial liver support across a membrane.
Topics: Ammonia; Animals; Endogenous Retroviruses; Extracorporeal Circulation; Galactose; Liver Circulation; Liver Failure, Acute; Liver, Artificial; Membranes, Artificial; Models, Cardiovascular; Perfusion; Sus scrofa; Virus Diseases | 2011 |
A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis.
Topics: Animals; Apoptosis; Concanavalin A; fas Receptor; Galactose; Gene Silencing; Gene Transfer Techniques; Hepatocytes; Inflammation; Liposomes; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Organ Specificity; Particle Size; RNA, Small Interfering; Static Electricity; Tissue Distribution | 2012 |
Improvement of C3A cell metabolism for usage in bioartificial liver support systems.
Topics: Albumins; Animals; Cell Line, Tumor; Cells, Cultured; Culture Media; Galactose; Gluconeogenesis; Hepatoblastoma; Hepatocytes; Humans; Liver Failure, Acute; Liver Neoplasms; Liver, Artificial; Swine; Time Factors; Urea | 2004 |
Iso and xeno fetal liver transplant therapy for the treatment of acute and chronic liver failure in rats.
Topics: Animals; Carbon Tetrachloride Poisoning; Chronic Disease; Fetal Tissue Transplantation; Galactose; Liver Failure; Liver Failure, Acute; Liver Transplantation; Necrosis; Rats; Rats, Wistar; Swine; Transplantation, Heterologous; Transplantation, Isogeneic | 1994 |
Effects of human HSS on hepatocyte and hepatoma cell proliferation and D-GAL induced acute liver failure.
Topics: Animals; Carcinoma, Hepatocellular; Cell Division; Fetus; Galactose; Growth Substances; Humans; Liver; Liver Failure, Acute; Liver Neoplasms; Liver Regeneration; Rats; Tumor Cells, Cultured | 1992 |
Metabonomic analysis of liver tissue from BALB/c mice with D-galactosamine/lipopolysaccharide-induced acute hepatic failure.
Topics: Amino Acids; Animals; Disease Models, Animal; Fatty Acids; Galactosamine; Gas Chromatography-Mass Spectrometry; Heptoses; Hexoses; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Maltose; Metabolome; Metabolomics; Mice; Mice, Inbred BALB C | 2013 |